A prospective, multicenter, clinical outcome study of the NANOS neck preserving stem in patients with degenerative hip joint disease.

A prospective, multicenter, clinical outcome study of the NANOS neck preserving stem in patients with degenerative hip joint disease. - NANOS Prospective clinical outcome study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46912

Enrollment

Registered

2010-09-03

Start date

2011-07-11

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis reumatoid arthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with degenerative hip disease, age 18-60, requiring a primary neck preserving hip arthroplasty (page 6).

Exclusion criteria

Exclusion criteria: Previous failed endoprosthesis, active local or systemic infection, general health with ASA>2, pronounced femur neck angle of 145 degrees, insufficient bone stock (femur or acetabulum), proven osteoporosis, body mass index >30. (page 7).

Design outcomes

Primary

Measure	Time frame
Survival rate at 10 years follow- up.	—

Secondary

Measure	Time frame
Clinical outcome: HHS, HOOS, UCLA and radiographic findings.	—

Countries

Netherlands

Outcome results